Company Monitoring Page for Amgen

latest headlines for company on cafepharma

How Cheap Is Amgen's Stock by the Numbers?
Motley Fool
Sat, 12/4/10 - 12:20 pm
Tags:
Amgen, investors
The Amgen Sales Rep, The Doctor And The Dog
Pharmalot
Wed, 12/1/10 - 12:10 pm
Tags:
Amgen, drug reps, physicians
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
Tags:
RNAi, Merck, Alnylam, Pfizer, Amgen, Novartis, Eli Lilly, Roche
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Tags:
Delcath, Arena Pharmaceuticals, RXi Pharmaceuticals, Cell Therapeutics, Amgen, Incyte, Celgene, Corcept Therapeutics, Affymax, Targacept, Exelixis, Orexigen, ONYX Pharmaceuticals, Seattle Genetics, MannKind, Alimera, AstraZeneca, Human Genome Sciences
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
Mon, 11/29/10 - 09:04 am
Tags:
M&A, Abbott Laboratories, Actelion, GSK, JNJ, Roche, Amgen, Bristol-Myers Squibb
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tue, 11/23/10 - 10:49 am
Tags:
Amgen, M&A, Actelion
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
Tags:
biotech, R&D, Amgen, Biogen Idec, Gilead Sciences, Genzyme, Celgene, Kyowa Hakko Kirin, Vertex Pharmaceuticals, Life Technologies, CSL, Amylin, Genmab, Cubist Pharmaceuticals, MannKind, companies, Merial
Actelion: Genzyme-Sanofi Redux?
WSJ Online
Mon, 11/22/10 - 10:32 am
Tags:
Genzyme, Actelion, Sanofi, M&A, Bayer, Amgen, AstraZeneca
One Drug, Two Names, Two Wildly Different Prospects
Motley Fool
Sat, 11/20/10 - 12:22 pm
Tags:
Amgen, Prolia, Xgeva, denosumab
Exclusive Picks From Street’s Top Biotech Analyst
CNBC
Sat, 11/20/10 - 12:15 pm
Tags:
Human Genome Sciences, Amgen, United Therapeutics
Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer Patients
Bloomberg
Sat, 11/20/10 - 12:10 pm
Tags:
Amgen, denosumab, cancer
Amgen's Xgeva Approved
Yahoo/Zacks.com
Fri, 11/19/10 - 11:16 am
Tags:
FDA, Amgen, Xgeva
Actelion, Eyed by Amgen, May Fetch $9.8 Billion in Takeover, Analysts Say
Bloomberg
Thu, 11/18/10 - 07:58 am
Tags:
Actelion, Amgen, M&A
Actelion shares surge (again) as M&A buzz hits fever pitch
Fierce Biotech
Wed, 11/17/10 - 11:46 am
Tags:
Actelion, M&A, Amgen
Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Bradenton Herald, FL
Sat, 11/6/10 - 01:25 pm
Tags:
Prolia, osteoporosis, Amgen
[video]Amgen in Focus
Yahoo/CNBC
Wed, 11/3/10 - 07:00 pm
Tags:
Kevin Sharer, Amgen, Pharma CEOs, healthcare reform
Time to Sell Amgen?
Motley Fool
Wed, 11/3/10 - 06:57 am
Tags:
Amgen
Amgen proposes key hurdles for biosimilar regs
Fierce Biotech
Tue, 11/2/10 - 11:27 am
Tags:
Amgen, biosimilars
Biotech Calendar: Key Dates for November
TheStreet.com
Fri, 10/29/10 - 12:11 pm
Tags:
biotech, Merck, Gilead Sciences, Indenix, Pharmasset, Bristol-Myers Squibb, Dendreon, Cadence Pharmaceuticals, Vical, MELA Sciences, Human Genome Sciences, Amgen
Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
Bloomberg
Wed, 10/27/10 - 11:50 am
Tags:
Amgen, Prolia, UK, NHS

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.